# Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects

> **NCT05715658** · NA · UNKNOWN · sponsor: **Dongyang Liu** · enrollment: 36 (estimated)

## Conditions studied

- Nonvalvular Atrial Fibrillation
- Health, Subjective

## Interventions

- **DRUG:** Dabigatran etexilate capsule

## Key facts

- **NCT ID:** NCT05715658
- **Lead sponsor:** Dongyang Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-15
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-30
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05715658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05715658, "Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05715658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*